Human urinary kallindinogenase therapy for acute ischemic stroke according to Chinese ischemic stroke subclassification: Clinical efficacy and risk factors

INTRODUCTION: To evaluate effectiveness of human urinary kallindinogenase (HUK) in patients with acute ischemic stroke (AIS) according to Chinese ischemic stroke subclassification (CISS) and analyzed risk factors of clinical efficacy. METHODS: In this retrospective study, 134 patients received conve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Si‐Qia, Mao, Dong‐Yang, Wei, Dun‐Can, He, Wen‐Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955840/
https://www.ncbi.nlm.nih.gov/pubmed/31793238
http://dx.doi.org/10.1002/brb3.1461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955840/
https://www.ncbi.nlm.nih.gov/pubmed/31793238
http://dx.doi.org/10.1002/brb3.1461

Ejemplares similares